Zidovudine for Thrombocytopenic Purpura Related to Human Immunodeficiency Virus (HIV) Infection
Authors:
- Philippe BierlingPBPhilippe Bierling
- Françoise FerchalFFFrançoise Ferchal
- Jean-Pierre ClauvelJCJean-Pierre Clauvel
- Maxime SeligmannMSMaxime Seligmann
- 1 March 1989
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 110 (5) , 365-368
Abstract
To determine whether zidovudine is effective in increasing the platelet count in patients with thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection. Nonrandomized controlled trial with two consecutive regimens. Immunopathology and hematology clinics at two general hospitals. Consecutive sample of 34 patients infected with HIV who had thrombocytopenic purpura (platelets less than 50 x 10(9)/L) without visceral bleeding. Twenty-nine patients completed the study; one patient was removed because of drug toxicity. Zidovudine for 12 weeks, 250 mg every 6 hours orally in 10 patients; and 500 mg every 8 hours orally in 24 patients. Three of ten patients receiving 250 mg every 6 hours and 12 of 24 patients receiving 500 mg every 8 hours had a persistent increase in their platelet counts. In both groups the mean value of the platelet count increased significantly by week 12; from 28 x 10(9)/L +/- 12 (SD) to 57 x 10(9)/L +/- 36 in the first group and from 20 x 10(9)/L +/- 13 to 77 x 10(9)/L +/- 42 in the second group (P less than 0.05 and P less than 0.01, respectively). Zidovudine is effective on platelet counts in some patients with HIV-related thrombocytopenia. These results suggest that HIV itself may play a direct or indirect role in the pathogenesis of this disorder.Keywords
This publication has 13 references indexed in Scilit:
- The Effect of Azidothymidine on HIV-Related ThrombocytopeniaNew England Journal of Medicine, 1988
- Response to therapy in 37 patients with HIV‐related thrombocytopenic purpuraBritish Journal of Haematology, 1987
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Response of AIDS-Related Thrombocytopenia to Intravenous and Oral Azidothymidine (3′-Azido-3′-Deoxythymidine)AIDS Research and Human Retroviruses, 1987
- Direct Polyclonal Activation of Human B Lymphocytes by the Acquired Immune Deficiency Syndrome VirusScience, 1986
- Antibodies to Human T-Lymphotropic Virus Type III and Development of the Acquired Immunodeficiency Syndrome in Homosexual Men Presenting with Immune ThrombocytopeniaAnnals of Internal Medicine, 1986
- RETRACTED: Target Platelet Antigen in Homosexual Men with Immune ThrombocytopeniaNew England Journal of Medicine, 1985
- Thrombocytopenia in Homosexual PatientsAnnals of Internal Medicine, 1985
- On the Mechanism of Thrombocytopenic Purpura in Sexually Active Homosexual MenNew England Journal of Medicine, 1984